Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles

Colloids and Surfaces B: Biointerfaces

Volumn 79, Issue 2, 2010, Pages 467-479

  Moretton, Marcela A ^a,b   Glisoni, Romina J ^a,b   Chiappetta, Diego A ^a,b   Sosnik, Alejandro ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Flower like polymeric micelles; Microwave Assisted Polymer Synthesis (MAPS); Poly(epsilon caprolactone) b poly(ethylene glycol) poly(epsilon caprolactone) block copolymers; Rifampicin encapsulation; Tuberculosis

Indexed keywords

FLOWER-LIKE; MICROWAVE-ASSISTED; POLY(EPSILON-CAPROLACTONE); POLYMER SYNTHESIS; POLYMERIC MICELLE; RIFAMPICIN ENCAPSULATION;

AGGLOMERATION; BLOCK COPOLYMERS; COPOLYMERIZATION; DYES; ETHYLENE; ETHYLENE GLYCOL; LIGHT TRANSMISSION; MICELLES; MOLECULAR WEIGHT; OPTICAL PROJECTORS; PLASTIC PRODUCTS; POLYETHYLENE OXIDES; POLYMERS; SCANNING ELECTRON MICROSCOPY; SURFACE TENSION; SYSTEM STABILITY; TRANSMISSION ELECTRON MICROSCOPY; VIRUSES; ZETA POTENTIAL;

POLYETHYLENE GLYCOLS;

CAPROLACTONE; COPOLYMER; ETHYLENE OXIDE; MACROGOL; POLYCAPROLACTONE; RIFAMPICIN; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; MICELLE; NANOMATERIAL; POLY(EPSILON-CAPROLACTONE)-B-POLY(ETHYLENEGLYCOL)-B-POLY(EPSILON-CAPROLACTONE); POLYESTER; TUBERCULOSTATIC AGENT; WATER;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; LIGHT SCATTERING; MICELLE; MICROWAVE RADIATION; MOLECULAR STABILITY; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE TENSION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECTS; NANOTECHNOLOGY; PROCEDURES; SOLUBILITY; SYNTHESIS; TEMPERATURE; ULTRASTRUCTURE;

ANTITUBERCULAR AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; MICELLES; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; RIFAMPIN; SOLUBILITY; TEMPERATURE; WATER;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77953915263     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.05.016     Document Type: Article

References (58)

1. Kaufmann S.H., McMichael A.J. Nat. Med. 2005, 11:S33.
2. Tuberculosis. The International Union Against Tuberculosis and Lung Disease. (accessed February 2008). http://www.theunion.org/tuberculosis/tuberculosis.html.
3. Smith I. Clin. Microb. Rev. 2003, 16:463.
4. Golden M.P., Vikram H.R. Am. Family Phys. 2005, 72:1761.
5. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., Dye C. Lancet 2003, 362:887.
6. Global tuberculosis control: surveillance, planning, financing, WHO report 2008. (accessed February 2008). http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf.
7. Jain S.K., Lamichhane G., Nimmagadda S., Pomper M.G., Bishai W.R. Microbe 2008, 3:285.
8. World Health Organization, Sozial- und Präventivmedizin 38 (1993) 251.
9. Onyebujoh P., Zumla A., Ribeiro I., Rustomjee R., Mwaba P., Gomes M., Grange J.M. Bull. World Health Organ. 2005, 83:857.
10. WHO, Treatment of tuberculosis: guidelines for national programmes, 3rd Geneva World Health Organization, 2003.
11. Dye C. Lancet 2006, 367:938.
12. Brewer T., Heymann S. Arch. Med. Res. 2005, 36:617.
13. Rivers E.C., Mancera R.L. Drug Discov. Today 2008, 13:1090.
14. Becker C., Dressman J.B., Junginger H.E., Kopp S., Midha K.K., Shah V.P., Stavchansky S., Barends D.M. J. Pharm. Sci. 2009, 98:2252.
15. Agrawal S., Panchagnula R. Int. J. Pharm. 2004, 287:97.
16. Zaru M., Mourtas S., Klepetsanis P., Fadda A.M., Antimisiaris S.G. Eur. J. Pharm. Biopharm. 2007, 67:655.
17. Mariappan T.T., Singh S. Int. J. Tuberc. Lung Dis. 2003, 7:797.
18. Mariappan T.T., Singh S. Clin. Res. Reg. Affairs 2006, 23:1.
19. Shishoo C.J., Shah S.A., Rathod I.S., Savale S.S., Kotecha J.S., Shah P.B. Int. J. Pharm. 1999, 190:109.
20. Singh S., Mariappan T.T., Sharda N., Kumar S., Chakrabarti A.K. Pharm. Pharmacol. Commun. 2000, 6:405.
21. Shishoo C.J., Shah S.A., Rathod I.S., Savale S.S., Vora M.J. Int. J. Pharm. 2001, 228:53.
22. Gohel M.C., Sarvaiya K.G. AAPS PharmSci.Tech. 2007, 8. Article 68.
23. Gallo G.G., Radaelli P. Analytical Profiles of Drug Substances 1976, vol. 5:467. Academic Press, Inc., Orlando, FL, USA.
24. Maggi N., Vigevani A., Gallo G.G., Pasqualucci C.R. J. Med. Chem. 1968, 11:936.
25. Ferreira D.A., Ferreira A.G., Vizzotto L., Federman Neto A., Gomes de Oliveira A. Braz. J. Pharm. Sci. 2004, 40:43.
26. Mehta S.K., Bhasin K.K., Mehta N., Dham S. Colloid Polym. Sci. 2005, 283:532.
27. Prakash Rao B., Sarasija S., Narendra C., Balasangameshwer Ars Pharm. 2006, 47:37.
28. Vijayaraj Kumar P., Asthana A., Dutta T., Jain N.K. J. Drug Target 2006, 14:546.
29. Sosnik A., Carcaboso A., Chiappetta D.A. Recent Pat. Biomed. Eng. 2008, 1:43.
30. Chiappetta D.A., Sosnik A. Eur. J. Pharm. Biopharm. 2007, 66:303.
31. Gonzalez-Lopez J., Alvarez-Lorenzo C., Taboada P., Sosnik A., Sandez-Macho I., Concheiro A. Langmuir 2008, 24:10688.
32. Piao L., Dai Z., Deng M., Chen X., Jing X. Polymer 2003, 44:2025.
33. Lin W.-J., Juang L.-W., Lin Ch-Ch. Pharm. Res. 2003, 20:668.
34. M.A. Moretton, R.J. Glisoni, D.A. Chiappetta, A. Sosnik, BIOOMAT 2009, I Workshop on Artificial Organs, Biomaterials and Tissue Engineering, Latin American Society of Biomaterials, Tissue Engineering and Artificial Organs (SLABO), Rosario, Argentina, August 2009.
35. Yang Y., Hua C., Dong Ch.M. Biomacromolecules 2009, 10:2310.
36. Gotelli G., Abraham G.A., Sosnik A. ARCHIPOL 2009-V Argentine-Chilean Polymer Symposium 2009.
37. Kappe C.O. Angew. Chem. Int. Ed. 2004, 43:6250.
38. European Pharmacopeia 3rd Edition, Supplement, Council of Europe (2000) 298.
39. Rote A.R., Sharma A.K. Int. J. Pharm. 1997, 59:119.
40. Schwach G., Vert M. Int. J. Biol. Macromol. 1999, 25:283.
41. Sosnik A., Cohn D. Polymer 2003, 44:7033.
42. Sánchez-Soto P.J., Ginés J.M., Arias M.J., Novák C.S., Ruiz-Conde A. J. Therm. Anal. Calorim. 2002, 67:189.
43. Dong J., Armstrong J., Chowdry B.Z., Leharne S.A. Therm. Acta 2004, 417:201.
44. Dong J., Chowdry B.Z., Leharne S.A. Colloids Surf. A 2004, 24:91.
45. Laird Forrest M., Yáñez J.A., Remsberg C.M., Ohgami Y., Kwon G.S., Davies N.M. Pharm. Res. 2008, 25:194.
46. Letchford K., Liggins R., Wasan K.M., Burt H. Eur. J. Pharm. Biopharm. 2009, 71:196.
47. Zhao Y., Liang H., Wang S., Wu C. J. Phys. Chem. B 2001, 105:848.
48. Letchford K., Liggins R., Burt H. J. Pharm. Sci. 2008, 97:1179.
49. Liu J., Zeng F., Allen C. Eur. J. Pharm. Biopharm. 2007, 65:309.
50. Hu Y., Ding Y., Li Y., Jiang X., Yang Ch., Yang Y. J. Nanosci. Nanotech. 2006, 6:3032.
51. Gaucher G., Dufresne M.-H., Sant V.P., Kang N., Maysinger D., Leroux J.-C. J Control Release 2005, 109:169.
52. Kabanov A.V., Nazarova I.R., Astafieva I.V., Batrakova E.V., Alakhov V.Y., Yaroslavov A.A., Kabanov V.A. Macromolecules 1995, 28:2303.
53. Chiappetta D.A., Hocht C., Taira C., Sosnik A. Nanomedicine 2010, 5:11.
54. Chiappetta D.A., Degrossi J., Teves S., DóAquino M., Bregni C., Sosnik A. Eur. J. Pharm. Biopharm. 2008, 69:535.
55. Changsan N., Nilkaeo A., Pungrassami P., Srichana T. J. Drug Target 2009, 17:751.
56. Sosnik A., Carcaboso A.M., Glisoni R.J., Moretton M.A., Chiappetta D.A. Adv. Drug Del. Rev. 2010, 62:547.
57. Sosnik A., Amiji M. Adv. Drug Del. Rev. 2010, 62:365.
58. Richter A., Olbrich C., Krause M., Hoffmann J., Kissel T. Eur. J Pharm. Biopharm. 2010, 10.1016/j.ejpb.2010.02.010.